CUMC Home | Columbia University | Jobs at CUMC | Contact CUMC | Find People
Columbia University Medical Center logo,Positioning Line Discover. Educate. Care. Lead., image for New York Skyline  

The Dean's Lecture Series
Alexander Ming Fisher Lecture

Dean's Distinguished Lecture in the Basic Sciences

The Cartwright Lecture

Dean's Distinguished Lecture in the Clinical Sciences

David Seegal Alpha Omega Alpha Visiting Professorship Lecture

Heidelberger-Kabat Lecture

Dean's Distinguished Lecture in the Humanities

Innovation in Biological and Medical Sciences Distinguished Lecture

Louisa Gross Horwitz Prize Lecture

Samuel Rudin Distinguished Visiting Professorship Lecture
past events

Thomas Q. Morris Symposia

Other Special Lectures and Events

Previous lectures:

Lecture Videos


The Samuel Rudin Distinguished Visiting

Professorship Lectures

Established at Columbia University in 1977 by a grant from the Samuel and May Rudin Foundation, the Samuel Rudin Distinguished Visiting Professorship program today serves as an important vehicle for the exchange of scientific knowledge among Columbia University, the greater New York City community, and academic institutions from around the world.

Since the inception of the Rudin visiting professorship program, Columbia has welcomed into the Rudin professorship program nearly 50 leading scholars, scientists, researchers, and medical practitioners, representing thirty-plus world-renowned scientific and medical institutions and nine countries worldwide.


Available Videos:
Speaker: Thomas R. Insel, MD
Lecture Date: April 13, 2015
Lecture Title: "Transforming the Diagnosis and Treatment of Mental Illness"

2014 - 2015 EVENTS

Thomas R. Insel, MD

Thomas R. Insel, MD
Director, National Institute of Mental Health,
National Institutes of Health

Transforming the Diagnosis and Treatment of Mental Illness
Monday, April 13, 2015
4:30 p.m.
Alumni Auditorium
650 West 168th Street, First Floor
Reception to follow in the auditorium lobby


Thomas R. Insel, MD, is director of the National Institute of Mental Health (NIMH), the component of the National Institutes of Health charged with generating knowledge to understand, treat, and prevent mental disorders. His tenure at NIMH has been distinguished by groundbreaking findings on the genetics and neurobiology of mental disorders as well as efforts to transform the diagnosis and treatment of serious mental illnesses. In addition to his leadership of NIMH, Dr. Insel has served as chair of the Interagency Autism Coordinating Committee (since 2002), co-chair of the NIH Blueprint for Neuroscience Research (since 2004), and acting director of the National Center for Advancing Translational Science (2011-2012). Currently, Dr. Insel is one of the leaders for the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) effort, a Presidential initiative focused on developing new tools for understanding the brain.

Before his appointment as NIMH director in 2002, Dr. Insel was professor of psychiatry at Emory University. There, he was founding director of the Center for Behavioral Neuroscience and director of an NIH-funded Center for Autism Research. From 1994 to 1999, he was director of the Yerkes Regional Primate Research Center in Atlanta. While at Emory, Dr. Insel continued the line of research he initiated at NIMH early in his career—studying the neurobiology of complex social behaviors. He has published more than 280 scientific articles and four books, including the “Neurobiology of Parental Care”(with Michael Numan) in 2003.

Dr. Insel is a member of the Institute of Medicine, a fellow of the American College of Neuropsychopharmacology, and a recipient of several awards, including the Outstanding Service Award from the U.S. Public Health Service and the 2010 La Fondation IPSEN Neuronal Plasticity Prize. Dr. Insel graduated from the combined B.A.­ M.D. program at Boston University in 1974. He did his internship at Berkshire Medical Center in Pittsfield, Mass., and his residency at the Langley Porter Neuropsychiatric Institute at the University of California, San Francisco.


Karl Deisseroth, MD, PhD, Stanford University

Bruce M. Spiegelman, PhD, Dana-Farber Cancer Institute and Harvard Medical School

Peter St George-Hyslop, MD, FRCP (C), FRS, University of Cambridge and University of Toronto

David Baltimore, Ph.D., California Institute of Technology

Eric Olson, Ph.D., UT Southwestern Medical Center at Dalles
View Lecture Video

Thomas C. Südhof, M.D., UT Southwestern Medical Center at Dallas

Jeffrey I. Gordon, M.D., Washington University School of Medicine

Ronald M. Evans, Ph.D., The Salk Institute, Howard Hughes Medical Institute

Dr. Michael Karin, University of California, San Diego

Dr. Roderick Mackinnon, Rockefeller University

Eric S. Lander, Ph.D., Whitehead Institute/MIT Center for Genome Research,
Massachusetts Institute of Technology

Richard Losick, Ph.D., Harvard University

Donald A. Henderson, Johns Hopkins University

Robert W. Mahley, University of California at San Francisco
Charles Weissman, University of Surich, Imperial College of Science, Technology and Medicine, London, England

James E. Rothman, Memorial Sloan-Kettering Institute

Laurie H. Glimcher, Harvard University
Francis S. Collins, National Institutes of Health

Solomon H. Snyder, Johns Hopkins University
Alan Fersht, Cambridge University

C. Thomas Caskey, Baylor College of Medicine
Michael E. Phelps, UCLA School of Medicine

Olikoye Ransome-Kuti, Federal Republic of Nigeria
Thomas E. Starzl, University of Pittsburgh

Jonathan Mann, Harvard Institute of Public Health, International AIDS Center, Boston, MA
Sydney Brenner, Molecular Genetics Unit, Cambridge, England

Geoffrey Thorburn, Monash University, Clayton, Australia
Jonathan Beckwith, Harvard University

Michael J. Berridge, University of Cambridge
Ira Herskowitz, University of California at San Francisco

Friedrich Bonhoeffer, Max Planck Institut, Tubingen, West Germany
Marc W. Kirschner, University of California at Berkeley

Sir Roy York Calne, University of Cambridge

Alexander Borbély, University of Zurich
Piet Borst, The Netherlands Cancer Institute

Tom Maniatis, Harvard University
Alexander Rich, Massachusetts Institute of Technology

Kurt Wüthrich, Eidgenossische Technische, Hoschule, Zurich
Daniel E. Koshland, Jr., University of California at Berkeley

Philippe Coumel, Hôpital Lariboisière, Paris
Joseph Martin, Harvard University

Peter J. Morris, Oxford University
Keith R. Yamamoto, University of California at San Francisco

Harold M. Weintraub, University of Washington

Charles Scriver, McGill University
Sir Richard Doll, Oxford University
Norman Geschwind, Harvard University

Efraim Racker, Cornell University
Leo Sachs, Weizmann Institute
Rozella M. Schlotfeldt, Case Western Reserve University
Paul Lacy, Washington University, St. Louis

Bruce N. Ames, University of California at Berkeley
Francis D. Moore, Harvard University
Baruj Benacerraf, Harvard University
David Mechanic, University of Wisconsin


back to top

CUMC Home | © Columbia University | Affiliated with New York-Presbyterian Hospital | Comments | Text-Only Version